Product Description: Trontinemab is a bispecific and humanizedized IgG1-κ antibody, targeting to amyloid beta A4 precursor protein (APP) and transferrin receptor, p90, CD71 (TFRC). Trontinemab can be used for research on Alzheimer disease (AD)[1][2].
Applications: Neuroscience-Neurodegeneration
Formula: N/A
References: [1]Trontinemab. IMGT/mAb-DB./[2]Duggan MR, et al. Herpes Viruses in the Baltimore Longitudinal Study of Aging: Associations With Brain Volumes, Cognitive Performance, and Plasma Biomarkers. Neurology. 2022 Aug 19;99(18):e2014–24.
CAS Number: 2568868-35-7
Molecular Weight: N/A
Compound Purity: 96.77
Research Area: Neurological Disease
Solubility: 10 mM in DMSO/H2O
Target: Amyloid-β